Want to see DRIO full AI Analyst Report?
DarioHealth (DRIO) Ratios
DarioHealth Ratios
DRIO's free cash flow for Q2 2026 was $-5.53M. For the 2026 fiscal year, DRIO's free cash flow was decreased by $-38.00K and operating cash flow was $-5.49M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.73 | 2.44 | 3.79 | 3.39 | 3.17 |
| Quick Ratio | 3.27 | 2.15 | 3.38 | 2.98 | 2.74 |
| Cash Ratio | 2.82 | 1.67 | 2.95 | 2.55 | 2.50 |
| Solvency Ratio | -0.92 | -0.75 | -1.42 | -1.47 | -4.75 |
| Operating Cash Flow Ratio | -2.78 | -2.32 | -2.43 | -2.47 | -3.51 |
| Short-Term Operating Cash Flow Coverage | -60.33 | -7.07 | -7.68 | -5.42 | -189.51 |
| Net Current Asset Value | $ -7.34M | $ -6.34M | $ 9.09M | $ 26.33M | $ 30.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.25 | 0.31 | 0.24 | 0.00 |
| Debt-to-Equity Ratio | 0.47 | 0.42 | 0.51 | 0.35 | 0.00 |
| Debt-to-Capital Ratio | 0.32 | 0.30 | 0.34 | 0.26 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.25 | 0.30 | 0.18 | 0.00 |
| Financial Leverage Ratio | 1.62 | 1.65 | 1.66 | 1.49 | 1.18 |
| Debt Service Coverage Ratio | -9.29 | -6.35 | -11.84 | -4.83 | -200.14 |
| Interest Coverage Ratio | -10.91 | -601.50 | -87.11 | -21.17 | -910.64 |
| Debt to Market Cap | 0.06 | 0.05 | 0.03 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.71 | 0.75 | 1.06 | 1.30 | 0.02 |
| Net Debt to EBITDA | -0.16 | -0.07 | 0.13 | 0.38 | 0.51 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.64% | 49.06% | 29.40% | 34.91% | 39.34% |
| EBIT Margin | -171.07% | -164.58% | -291.68% | -218.08% | -363.06% |
| EBITDA Margin | -157.04% | -137.12% | -267.19% | -201.03% | -341.33% |
| Operating Profit Margin | -163.94% | -213.55% | -276.09% | -205.42% | -372.90% |
| Pretax Profit Margin | -186.10% | -164.94% | -291.68% | -224.87% | -374.05% |
| Net Profit Margin | -186.56% | -158.09% | -292.00% | -224.88% | -374.21% |
| Continuous Operations Profit Margin | -186.56% | -158.09% | -292.00% | -224.88% | -374.21% |
| Net Income Per EBT | 100.25% | 95.85% | 100.11% | 100.01% | 100.04% |
| EBT Per EBIT | 113.52% | 77.24% | 105.65% | 109.47% | 100.31% |
| Return on Assets (ROA) | -37.90% | -35.96% | -61.65% | -52.18% | -76.17% |
| Return on Equity (ROE) | -61.41% | -59.36% | -102.21% | -77.74% | -89.73% |
| Return on Capital Employed (ROCE) | -36.38% | -56.47% | -66.97% | -56.90% | -88.54% |
| Return on Invested Capital (ROIC) | -36.23% | -51.15% | -63.88% | -52.14% | -88.27% |
| Return on Tangible Assets | -113.61% | -100.12% | -120.43% | -91.95% | -164.47% |
| Earnings Yield | -7.39% | -6.73% | -6.09% | -3.07% | -1.78% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.37 | 5.05 | 5.59 | 4.31 | 11.49 |
| Payables Turnover | 3.31 | 4.52 | 12.70 | 7.75 | 2.44 |
| Inventory Turnover | 2.25 | 2.90 | 2.84 | 2.26 | 2.00 |
| Fixed Asset Turnover | 17.66 | 15.24 | 10.91 | 13.87 | 20.74 |
| Asset Turnover | 0.20 | 0.23 | 0.21 | 0.23 | 0.20 |
| Working Capital Turnover Ratio | 0.91 | 0.92 | 0.50 | 0.71 | 0.70 |
| Cash Conversion Cycle | 95.86 | 117.51 | 165.20 | 198.92 | 64.60 |
| Days of Sales Outstanding | 43.60 | 72.24 | 65.33 | 84.68 | 31.78 |
| Days of Inventory Outstanding | 162.51 | 125.96 | 128.59 | 161.32 | 182.68 |
| Days of Payables Outstanding | 110.25 | 80.70 | 28.73 | 47.08 | 149.85 |
| Operating Cycle | 206.11 | 198.20 | 193.93 | 246.00 | 214.46 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.52 | -0.95 | -1.07 | -2.02 | -3.04 |
| Free Cash Flow Per Share | -0.53 | -0.96 | -1.09 | -2.05 | -3.05 |
| Dividend Paid and CapEx Coverage Ratio | -182.68 | -279.43 | -52.02 | -83.50 | -193.14 |
| Capital Expenditure Coverage Ratio | -182.68 | -279.43 | -52.02 | -83.50 | -193.14 |
| Operating Cash Flow Coverage Ratio | -0.82 | -1.28 | -1.03 | -1.71 | -175.64 |
| Operating Cash Flow to Sales Ratio | -1.16 | -1.43 | -1.49 | -1.73 | -2.46 |
| Free Cash Flow Yield | -4.62% | -6.09% | -3.17% | -2.39% | -1.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.05 | -14.86 | -16.42 | -32.53 | -56.07 |
| Price-to-Sales (P/S) Ratio | 25.26 | 23.50 | 47.96 | 73.15 | 209.81 |
| Price-to-Book (P/B) Ratio | 8.32 | 8.82 | 16.79 | 25.29 | 50.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -21.65 | -16.42 | -31.52 | -41.79 | -84.94 |
| Price-to-Operating Cash Flow Ratio | -21.77 | -16.48 | -32.13 | -42.29 | -85.38 |
| Price-to-Earnings Growth (PEG) Ratio | -1.49 | 0.24 | 0.62 | 0.75 | 3.38 |
| Enterprise Value Multiple | -16.24 | -17.20 | -17.81 | -36.01 | -60.96 |
| Enterprise Value | 570.30M | 637.79M | 968.74M | 2.00B | 4.27B |
| EV to EBITDA | -16.24 | -17.20 | -17.81 | -36.01 | -60.96 |
| EV to Sales | 25.51 | 23.59 | 47.60 | 72.38 | 208.07 |
| EV to Free Cash Flow | -21.86 | -16.48 | -31.29 | -41.35 | -84.23 |
| EV to Operating Cash Flow | -21.98 | -16.54 | -31.89 | -41.84 | -84.67 |
| Tangible Book Value Per Share | -0.11 | -0.10 | 0.39 | 1.20 | 1.90 |
| Shareholders’ Equity Per Share | 1.37 | 1.78 | 2.05 | 3.38 | 5.16 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.04 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.45 | 0.67 | 0.72 | 1.17 | 1.24 |
| Net Income Per Share | -0.84 | -1.06 | -2.09 | -2.63 | -4.63 |
| Tax Burden | 1.00 | 0.96 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.09 | 1.00 | 1.00 | 1.03 | 1.03 |
| Research & Development to Revenue | 0.62 | 0.89 | 0.99 | 0.71 | 0.84 |
| SG&A to Revenue | 1.59 | 1.73 | 0.89 | 0.60 | 1.10 |
| Stock-Based Compensation to Revenue | 0.42 | 0.58 | 0.97 | 0.61 | 1.22 |
| Income Quality | 0.62 | 0.90 | 0.51 | 0.77 | 0.66 |
Currency in USD
